<DOC>
	<DOC>NCT00778531</DOC>
	<brief_summary>The purpose of this post-approval study is to evaluate the continuing safety of ArteFill as an injectable implant for correction of nasolabial folds over the course of five years post implantation, with a focus on determining the incidence of granuloma formation. Incidence of adverse events and subject satisfaction with respect to the subject's personal expectations will be assessed.</brief_summary>
	<brief_title>Protocol for the Post-approval Study of ArteFillÂ® for Correction of Nasolabial Folds</brief_title>
	<detailed_description>This study is a multi-center, non-randomized, non-controlled post-approval study designed to follow a total of 1000 consecutive qualified and consenting subjects treated with ArteFill in the course of clinical practice at approximately twenty-five centers. All potential qualifying subjects at a given site should be given the opportunity to participate in the study. Inclusion and exclusion criteria will be limited to those in the approved labeling for ArteFill and treatment will be according to the approved product labeling. Subjects must have a previously documented negative skin test prior to treatment.</detailed_description>
	<mesh_term>Polymethyl Methacrylate</mesh_term>
	<criteria>Subject is male or nonpregnant female 18 years of age or older. Subject has provided written and verbal informed consent. Subject is willing to comply with study instructions and return to the clinic for required visits. Subject is willing to withhold additional aesthetic implant therapies to the NLF [e.g., other soft tissue fillers: Restylane, Silicone, Radiesse, Sculptra) or implants: gortex, silastic, thread lift, etc.] for the duration of the study. Subject has any skin pathology or condition that could interfere with the evaluation of the treatment areas. Subject has a history of systemic granulomatous diseases active or inactive (e.g.Sarcoid, Wegeners, TB, etc.) or connective tissue diseases (.e.g., lupus,dermatomyositis, etc.). Subject is immunocompromised in the opinion of the investigator because of disease or medical therapy (e.g., HIV, use of chemotherapy, etc.) Subject has been treated with any of the following in their NLF in the time intervals specified prior to the start of their participation in the study: Bovine collagen 6 months Porcine or human collagen one year Hyaluronic acid one year Hydroxylapatite one year Autologous fat at any time Polymethylmethacrylate or other acrylates at any time Polyacrylamide at any time Polyethylene oxide at any time Polylactic acid at any time Liquid silicone at any time Other permanent implant material (FDA approved or not) at any time Subject has had the placement of any surgical implants in the NL folds region(e.g., Gortex, Silastic implants, thread lifts, etc.) at any time. Subject has a history of multiple severe allergies or allergies manifested by anaphylaxis. Subject has a history of allergy to lidocaine. Subject has a history of allergies to any bovine collagen products, including but not limited to injectable collagen, collagen implants, hemostatic sponges, and collagenbased sutures. The subject has known hypersensitivity or previous allergic reaction to any of the components of the study devices not previously mentioned. Subject is undergoing or planning to undergo desensitization injections to meat products. Subject has any condition which, in the Investigator's opinion, would make it unsafe for the subject to participate in this research study. Subject is unable to communicate or cooperate with the Investigator due to language problems, poor mental development, or impaired cerebral function. Subject may be unreliable for the study including subjects who engage in excessive alcohol intake or drug abuse, or subjects who are unable to return for scheduled followup visits.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>injectable implant</keyword>
	<keyword>nasolabial folds</keyword>
	<keyword>Correction of nasolabial folds</keyword>
</DOC>